BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21821155)

  • 1. MicroRNA in HCV infection and liver cancer.
    Kumar A
    Biochim Biophys Acta; 2011; 1809(11-12):694-9. PubMed ID: 21821155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
    Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
    J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus-related hepatocellular carcinoma and liver cirrhosis.
    Pecic V; Stankovic-Djordjevic D; Nestorovic M; Radojkovic M; Marjanovic H; Ilic B; Milojkovic M
    J BUON; 2011; 16(2):277-81. PubMed ID: 21766498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex interactions between microRNAs and hepatitis B/C viruses.
    Fan HX; Tang H
    World J Gastroenterol; 2014 Oct; 20(37):13477-92. PubMed ID: 25309078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MicroRNAs in hepatocarcinogenesis].
    Lendvai G; Kiss A; Kovalszky I; Schaff Z
    Orv Hetil; 2012 Jun; 153(25):978-89. PubMed ID: 22714032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host.
    Thibault PA; Wilson JA
    Pharmacol Res; 2013 Sep; 75():48-59. PubMed ID: 23541631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion of information throughout the host interactome reveals gene expression variations in network proximity to target proteins of hepatitis C virus.
    Mosca E; Alfieri R; Milanesi L
    PLoS One; 2014; 9(12):e113660. PubMed ID: 25461596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus NS3 protein modulates the biological behaviors of malignant hepatocytes by altering the expression of host cell microRNA.
    Zhang J; Ishigaki Y; Takegami T
    Mol Med Rep; 2015 Oct; 12(4):5109-15. PubMed ID: 26151503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-mediated interactions between host and hepatitis C virus.
    Li H; Jiang JD; Peng ZG
    World J Gastroenterol; 2016 Jan; 22(4):1487-96. PubMed ID: 26819516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of microRNAs in hepatitis B virus replication and pathogenesis.
    Liu WH; Yeh SH; Chen PJ
    Biochim Biophys Acta; 2011; 1809(11-12):678-85. PubMed ID: 21565290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional sequestration of microRNA-122 from Hepatitis C Virus by circular RNA sponges.
    Jost I; Shalamova LA; Gerresheim GK; Niepmann M; Bindereif A; Rossbach O
    RNA Biol; 2018; 15(8):1032-1039. PubMed ID: 29486652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway.
    Ishida H; Tatsumi T; Hosui A; Nawa T; Kodama T; Shimizu S; Hikita H; Hiramatsu N; Kanto T; Hayashi N; Takehara T
    Biochem Biophys Res Commun; 2011 Aug; 412(1):92-7. PubMed ID: 21802413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C viral RNA: challenges and promises.
    Shi ST; Lai MM
    Cell Mol Life Sci; 2001 Aug; 58(9):1276-95. PubMed ID: 11577984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virus.
    Takeda H; Takai A; Iguchi E; Mishima M; Arasawa S; Kumagai K; Eso Y; Shimizu T; Takahashi K; Ueda Y; Taura K; Hatano E; Iijima H; Aoyagi H; Aizaki H; Marusawa H; Wakita T; Seno H
    Carcinogenesis; 2021 May; 42(5):672-684. PubMed ID: 33617626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets.
    Zhang Q; Pu R; Du Y; Han Y; Su T; Wang H; Cao G
    Cancer Lett; 2012 Aug; 321(1):1-12. PubMed ID: 22425745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult hepatitis C virus infection: what does it mean?
    Pham TN; Coffin CS; Michalak TI
    Liver Int; 2010 Apr; 30(4):502-11. PubMed ID: 20070513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
    Ura S; Honda M; Yamashita T; Ueda T; Takatori H; Nishino R; Sunakozaka H; Sakai Y; Horimoto K; Kaneko S
    Hepatology; 2009 Apr; 49(4):1098-112. PubMed ID: 19173277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B Virus Infection, MicroRNAs and Liver Disease.
    Sarkar N; Chakravarty R
    Int J Mol Sci; 2015 Aug; 16(8):17746-62. PubMed ID: 26247932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
    Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA
    Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.